Regeneron Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
AMGNAmgen, Inc. 1.11%246.531.3%$804.75m
IMMUImmunomedics, Inc. 0.12%85.4611.0%$698.00m
MRNAModerna, Inc. 1.32%70.390.0%$675.31m
NVAXNovavax, Inc. -3.72%109.3496.5%$605.63m
ILMNIllumina, Inc. 0.91%302.623.5%$588.10m
GILDGilead Sciences, Inc. 0.98%62.861.0%$579.74m
REGNRegeneron Pharmaceuticals, Inc. -1.86%563.402.7%$435.15m
BIIBBiogen, Inc. 4.08%284.441.6%$348.65m
VRTXVertex Pharmaceuticals, Inc. -0.71%266.281.9%$338.44m
ALXNAlexion Pharmaceuticals, Inc. -0.98%113.312.0%$282.42m
EXASEXACT Sciences Corp. 2.02%99.6720.7%$262.48m
SRNESorrento Therapeutics, Inc. 5.97%10.211.5%$255.24m
SGENSeattle Genetics, Inc. 2.18%188.986.0%$216.76m
VXRTVaxart, Inc. -6.35%6.930.0%$200.30m
MNTAMomenta Pharmaceuticals, Inc. 0.08%52.443.0%$193.73m

Company Profile

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.